Novantrone and leukopenia Patient Reports February 11, 2012

Novantrone Side Effects Report #5527745-4
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Nov 14, 2007. Female patient, 67 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: completed suicide, leukopenia. Novantrone dosage: 100 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with TRAMADOL, RAMIPRIL, DULOXETINE. Patient died on 09/29/2007.

Novantrone Side Effects Report #5536714-X
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Nov 20, 2007. Female patient, 67 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: completed suicide, leukopenia. Novantrone dosage: 100 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with TRAMADOL, RAMIPRIL, DULOXETINE. Patient died on 09/29/2007.

Novantrone Side Effects Report #5018333-7
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient, 51 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: condition aggravated, leukopenia, multiple sclerosis , septic shock, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5527723-5
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Nov 09, 2007. Male patient, 29 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, psychotic disorder . Novantrone dosage: 110 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient was hospitalized. Patient recovered.


Novantrone Side Effects Report #5018321-0
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5018339-8
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5018351-9
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5018359-3
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5018363-5
Novantrone side effect was reported by a Physician from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Novantrone Side Effects Report #5018377-5
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5018380-5
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, urosepsis. Novantrone dosage: 12 MG/M2, 1 IN 12 WEEKS, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #4837173-2
Novantrone side effect was reported by a Physician from UNITED STATES on Nov 09, 2005. Male patient, 58 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, leukopenia, thrombocytopenia. Novantrone dosage: unknown. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #4666264-4
Novantrone side effect was reported by a Consumer or non-health professional from on May 05, 2005. Male patient, 50 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, leukopenia, neutropenia, platelet count decreased. Novantrone dosage: unknown. During the same period patient was treated with COPAXONE. Patient recovered.

Novantrone Side Effects Report #5092877-4
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 43 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: blood test abnormal, leukopenia, neutrophil count decreased, urinary tract infection . Novantrone dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.


Novantrone Side Effects Report #4574744-5
Novantrone side effect was reported by a Physician from on Jan 26, 2005. Male patient, 43 years of age, weighting 170.0 lb, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, catheter site haemorrhage, epistaxis, gingival bleeding, haemorrhage intracranial, leukopenia, red blood cell count decreased. Novantrone dosage: 21 MG, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with REBIF, COPAXONE. Patient was hospitalized. Patient died on 01/24/2005.

Novantrone Side Effects Report #5235182-5
Novantrone side effect was reported by a Health Professional from FRANCE on Feb 02, 2007. Female patient, 35 years of age, weighting 187.4 lb, was diagnosed with acute myeloid leukaemia, infection prophylaxis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: bacteraemia, cardiac arrest , condition aggravated, jaundice , leukopenia, neutropenia, thrombocytopenia. Novantrone dosage: unknown. During the same period patient was treated with ZELITREX, GEMTUZUMAB OZOGAMICIN, BACTRIM, TRIFLUCAN, ARACYTINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/07/2006.

Novantrone Side Effects Report #5246125-2
Novantrone side effect was reported by a Consumer or non-health professional from FRANCE on Feb 09, 2007. Female patient, 35 years of age, was diagnosed with acute myeloid leukaemia, infection prophylaxis and was treated with Novantrone. After drug was administered, patient experienced the following side effects: bacteraemia, cardiac arrest , condition aggravated, jaundice , leukopenia, neutropenia, thrombocytopenia. Novantrone dosage: 24 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with CYTARABINE, BACTRIM, DEXAMETHASONE, GEMTUZUMAB OZOGAMICIN, FLUCONAZOLE, VALACYCLOVIR. Patient was hospitalized. Patient died on 10/07/2006.

Novantrone Side Effects Report #5237936-8
Novantrone side effect was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2007. Female patient, 58 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia, pyrexia. Novantrone dosage: 18.84 MG, 1 IN 1 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with BROMAZEPAM, ESOMEPRAZOLE MAGNESIUM, PARACETAMOL, TIANEPTINE. Patient recovered.

Novantrone Side Effects Report #5194406-3
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2006. Female patient, 58 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia, pyrexia. Novantrone dosage: 18.84 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with BROMAZEPAM, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, TIANEPTINE. Patient recovered.


Novantrone Side Effects Report #5195989-X
Novantrone side effect was reported by a Consumer or non-health professional from FRANCE on Dec 14, 2006. Female patient, 41 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, leukopenia, thrombocytopenia. Novantrone dosage: 18 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE SUCCINATE, BROMAZEPAM, VENLAFAXINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.